• 2021
  Dupont MSJ, Guillemot V, Campagne P, Serafini N, Marie S, Montagutelli X, Di Santo JP, Vosshenrich CAJ, , Host genetic control of natural killer cell diversity revealed in the Collaborative Cross., Proc Natl Acad Sci U S A 2021 Mar; 118(10): .
• 2019
  Xu W, Cherrier DE, Chea S, Vosshenrich C, Serafini N, Petit M, Liu P, Golub R, Di Santo JP, , An Id2RFP-Reporter Mouse Redefines Innate Lymphoid Cell Precursor Potentials., Immunity 2019 04; 50(4): 1054-1068.e3.
• 2019
  Dupont M, Vosshenrich CAJ, , Conditional Genetic Ablation Mouse Models as a Tool to Study Cancer Immunosurveillance In Vivo., Methods Mol Biol 2019 ; 1884(): 161-176.
• 2017
  Lim AI, Verrier T, Vosshenrich CA, Di Santo JP, , Developmental options and functional plasticity of innate lymphoid cells., Curr Opin Immunol 2017 Feb; 44(): 61-68.
• 2016
  Chea S, Perchet T, Petit M, Verrier T, Guy-Grand D, Banchi EG, Vosshenrich CA, Di Santo JP, Cumano A, Golub R, Notch signaling in group 3 innate lymphoid cells modulates their plasticity, Sci Signal 2016;9(426):ra45.
• 2016
  Verrier T, Satoh-Takayama N, Serafini N, Marie S, Di Santo JP, Vosshenrich CA, Phenotypic and Functional Plasticity of Murine Intestinal NKp46+ Group 3 Innate Lymphoid Cells, J. Immunol. 2016 Jun;196(11):4731-8.
• 2015
  Serafini N, Vosshenrich CA, Di Santo JP, Transcriptional regulation of innate lymphoid cell fate, Nat. Rev. Immunol. 2015 Jul;15(7):415-28.
• 2015
  Xu W, Domingues RG, Fonseca-Pereira D, Ferreira M, Ribeiro H, Lopez-Lastra S, Motomura Y, Moreira-Santos L, Bihl F, Braud V, Kee B, Brady H, Coles MC, Vosshenrich C, Kubo M, Di Santo JP, Veiga-Fernandes H, , NFIL3 orchestrates the emergence of common helper innate lymphoid cell precursors., Cell Rep 2015 Mar; 10(12): 2043-54.
• 2014
  Sepulveda FE, Maschalidi S, Vosshenrich CA, Garrigue A, Kurowska M, Ménasche G, Fischer A, Di Santo JP, de Saint Basile G, A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice, Blood 2015 Feb;125(9):1427-34.
• 2014
  Merzoug LB, Marie S, Satoh-Takayama N, Lesjean S, Albanesi M, Luche H, Fehling HJ, Di Santo JP, Vosshenrich CA, Conditional ablation of NKp46+ cells using a novel Ncr1(greenCre) mouse strain: NK cells are essential for protection against pulmonary B16 metastases, Eur. J. Immunol. 2014 Nov;44(11):3380-91.
• 2014
  Serafini N, Klein Wolterink RG, Satoh-Takayama N, Xu W, Vosshenrich CA, Hendriks RW, Di Santo JP, Gata3 drives development of RORγt+ group 3 innate lymphoid cells, J. Exp. Med. 2014 Feb;211(2):199-208.
• 2013
  Vallese D, Negroni E, Duguez S, Ferry A, Trollet C, Aamiri A, Vosshenrich CA, Füchtbauer EM, Di Santo JP, Vitiello L, Butler-Browne G, Mouly V, The Rag2⁻Il2rb⁻Dmd⁻ mouse: a novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies, Mol. Ther. 2013 Oct;21(10):1950-7.
• 2013
  Klein Wolterink RG, Serafini N, van Nimwegen M, Vosshenrich CA, de Bruijn MJ, Fonseca Pereira D, Veiga Fernandes H, Hendriks RW, Di Santo JP, Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells, Proc. Natl. Acad. Sci. U.S.A. 2013 Jun;110(25):10240-5.
• 2013
  Vosshenrich CA, Di Santo JP, Developmental programming of natural killer and innate lymphoid cells, Curr. Opin. Immunol. 2013 Apr;25(2):130-8.
• 2011
  Satoh-Takayama N, Lesjean-Pottier S, Sawa S, Vosshenrich CA, Eberl G, Di Santo JP, Lymphotoxin-β receptor-independent development of intestinal IL-22-producing NKp46+ innate lymphoid cells, Eur. J. Immunol. 2011 Mar;41(3):780-6.
• 2010
  Elkabets M, Ribeiro VS, Dinarello CA, Ostrand-Rosenberg S, Di Santo JP, Apte RN, Vosshenrich CA, IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function, Eur. J. Immunol. 2010 Dec;40(12):3347-57.
• 2010
  Klein Wolterink RG, García-Ojeda ME, Vosshenrich CA, Hendriks RW, Di Santo JP, The intrathymic crossroads of T and NK cell differentiation, Immunol. Rev. 2010 Nov;238(1):126-37.
• 2010
  Ribeiro VS, Hasan M, Wilson A, Boucontet L, Pereira P, Lesjean-Pottier S, Satoh-Takayama N, Di Santo JP, Vosshenrich CA, Cutting edge: Thymic NK cells develop independently from T cell precursors, J. Immunol. 2010 Nov;185(9):4993-7.
• 2010
  Di Santo JP, Vosshenrich CA, Satoh-Takayama N, A ‘natural’ way to provide innate mucosal immunity, Curr. Opin. Immunol. 2010 Aug;22(4):435-41.
• 2010
  Satoh-Takayama N, Lesjean-Pottier S, Vieira P, Sawa S, Eberl G, Vosshenrich CA, Di Santo JP, IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors, J. Exp. Med. 2010 Feb;207(2):273-80.
• 2009
  Satoh-Takayama N, Dumoutier L, Lesjean-Pottier S, Ribeiro VS, Mandelboim O, Renauld JC, Vosshenrich CA, Di Santo JP, The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium, J. Immunol. 2009 Nov;183(10):6579-87.
• 2008
  Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, Sawa S, Lochner M, Rattis F, Mention JJ, Thiam K, Cerf-Bensussan N, Mandelboim O, Eberl G, Di Santo JP, Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense, Immunity 2008 Dec;29(6):958-70.
• 2007
  Vosshenrich CA, Lesjean-Pottier S, Hasan M, Richard-Le Goff O, Corcuff E, Mandelboim O, Di Santo JP, CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells, J. Exp. Med. 2007 Oct;204(11):2569-78.
• 2007
  Huntington ND, Vosshenrich CA, Di Santo JP, Developmental pathways that generate natural-killer-cell diversity in mice and humans, Nat. Rev. Immunol. 2007 Sep;7(9):703-14.
• 2006
  Di Santo JP, Vosshenrich CA, Bone marrow versus thymic pathways of natural killer cell development, Immunol. Rev. 2006 Dec;214:35-46.
• 2006
  Vosshenrich CA, García-Ojeda ME, Samson-Villéger SI, Pasqualetto V, Enault L, Richard-Le Goff O, Corcuff E, Guy-Grand D, Rocha B, Cumano A, Rogge L, Ezine S, Di Santo JP, A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127, Nat. Immunol. 2006 Nov;7(11):1217-24.
• 2006
  Liu A, Vosshenrich CA, Lagresle-Peyrou C, Malassis-Seris M, Hue C, Fischer A, Di Santo JP, Cavazzana-Calvo M, Competition within the early B-cell compartment conditions B-cell reconstitution after hematopoietic stem cell transplantation in nonirradiated recipients, Blood 2006 Aug;108(4):1123-8.
• 2005
  Vosshenrich CA, Samson-Villéger SI, Di Santo JP, Distinguishing features of developing natural killer cells, Curr. Opin. Immunol. 2005 Apr;17(2):151-8.
• 2005
  Vosshenrich CA, Ranson T, Samson SI, Corcuff E, Colucci F, Rosmaraki EE, Di Santo JP, Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo, J. Immunol. 2005 Feb;174(3):1213-21.
• 2004
  Vosshenrich CA, Cumano A, Müller W, Di Santo JP, Vieira P, Pre-B cell receptor expression is necessary for thymic stromal lymphopoietin responsiveness in the bone marrow but not in the liver environment, Proc. Natl. Acad. Sci. U.S.A. 2004 Jul;101(30):11070-5.
• 2004
  Samson SI, Mémet S, Vosshenrich CA, Colucci F, Richard O, Ndiaye D, Israël A, Di Santo JP, Combined deficiency in IkappaBalpha and IkappaBepsilon reveals a critical window of NF-kappaB activity in natural killer cell differentiation, Blood 2004 Jun;103(12):4573-80.
• 2003
  Samson SI, Richard O, Tavian M, Ranson T, Vosshenrich CA, Colucci F, Buer J, Grosveld F, Godin I, Di Santo JP, GATA-3 promotes maturation, IFN-gamma production, and liver-specific homing of NK cells, Immunity 2003 Nov;19(5):701-11.
• 2003
  Vosshenrich CA, Cumano A, Müller W, Di Santo JP, Vieira P, Thymic stromal-derived lymphopoietin distinguishes fetal from adult B cell development, Nat. Immunol. 2003 Aug;4(8):773-9.
• 2003
  Ranson T, Vosshenrich CA, Corcuff E, Richard O, Laloux V, Lehuen A, Di Santo JP, IL-15 availability conditions homeostasis of peripheral natural killer T cells, Proc. Natl. Acad. Sci. U.S.A. 2003 Mar;100(5):2663-8.
• 2003
  Ranson T, Vosshenrich CA, Corcuff E, Richard O, Müller W, Di Santo JP, IL-15 is an essential mediator of peripheral NK-cell homeostasis, Blood 2003 Jun;101(12):4887-93.
• 2002
  Vosshenrich CA, Di Santo JP, Interleukin signaling, Curr. Biol. 2002 Nov;12(22):R760-3.
• 2001
  Montrasio F, Cozzio A, Flechsig E, Rossi D, Klein MA, Rülicke T, Raeber AJ, Vosshenrich CA, Proft J, Aguzzi A, Weissmann C, B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice, Proc. Natl. Acad. Sci. U.S.A. 2001 Mar;98(7):4034-7.
• 2001
  Vosshenrich CA, Di Santo JP, Cytokines: IL-21 joins the gamma(c)-dependent network?, Curr. Biol. 2001 Mar;11(5):R175-7.
• 2000
  Vosshenrich CA, Sharara LI, Guy-Grand D, Rajewsky K, Müller W, Di Santo JP, Common cytokine receptor gamma chain (gammac)-deficient B cells persist in T cell-deficient gammac-mice and respond to a T-independent antigen, Eur. J. Immunol. 2000 Jun;30(6):1614-22.
• 1997
  Sharara LI, Vosshenrich CA, Müller W, DiSanto JP, On the role of the common cytokine receptor gamma chain in B-cell vs. T-cell development, Res. Immunol. 1997 Sep;148(7):449-53.
• 1996
  Betz UA, Vosshenrich CA, Rajewsky K, Müller W, Bypass of lethality with mosaic mice generated by Cre-loxP-mediated recombination, Curr. Biol. 1996 Oct;6(10):1307-16.